Biolife Solutions (BLFS) Current Assets (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Current Assets of $133.2 million for Q1 2026, up 1.6% year-over-year from $131.1 million in Q1 2025, and down 2.45% quarter-over-quarter from $136.6 million in Q4 2025.
Biolife Solutions (BLFS) Current Assets (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Current Assets for 17 consecutive years, with $133.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 1.6% year-over-year to $133.2 million; the TTM figure through Mar 2026 stood at $133.2 million (up 1.6% YoY), while the FY2025 annual figure was $136.6 million, down 8.2% from the prior year.
- Current Assets declined to $133.2 million in Q1 2026 per BLFS's latest filing, from $136.6 million in the prior quarter.
- Across five years, Current Assets topped out at $148.8 million in Q4 2024 and bottomed at $88.2 million in Q2 2024.
- Historically, Current Assets has averaged $123.1 million across 5 years, with a median of $125.4 million in 2025.
- Annual changes were most pronounced in 2024 — Current Assets decreased 26.69% — and 2025, when it jumped 42.21%.
- Biolife Solutions' Current Assets stood at $138.5 million in 2022, then slipped by 12.89% to $120.6 million in 2023, then rose by 23.35% to $148.8 million in 2024, then retreated by 8.2% to $136.6 million in 2025, then declined by 2.45% to $133.2 million in 2026.
- Business Quant data shows BLFS's Current Assets at $133.2 million in Q1 2026, $136.6 million in Q4 2025, and $126.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 9.54 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 8.14 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 6.62 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.32 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 11.74 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.81 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.74 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 2.30 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.99 Bn |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | 135.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 135.20 Mn |
| Mar 31, 2026 | 133.22 Mn |
| Dec 31, 2025 | 136.56 Mn |
| Sep 30, 2025 | 126.57 Mn |
| Jun 30, 2025 | 125.43 Mn |
| Mar 31, 2025 | 131.13 Mn |
| Dec 31, 2024 | 148.76 Mn |
| Sep 30, 2024 | 89.38 Mn |
| Jun 30, 2024 | 88.20 Mn |
| Mar 31, 2024 | 111.70 Mn |
| Dec 31, 2023 | 120.60 Mn |
| Sep 30, 2023 | 116.82 Mn |
| Jun 30, 2023 | 120.31 Mn |
| Mar 31, 2023 | 132.79 Mn |
| Dec 31, 2022 | 138.45 Mn |
| Sep 30, 2022 | 136.22 Mn |
| Jun 30, 2022 | 118.36 Mn |
| Mar 31, 2022 | 118.97 Mn |
| Dec 31, 2021 | 126.09 Mn |
| Sep 30, 2021 | 130.51 Mn |